Application of personalised medicine: opportunities and challenges Pharmacotherapy based on individual patient characteristics such as genetic makeup, offers many potential benefits towards more effective treatment of a patients’ disease.
Strict diet combats aging diseases Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want.
Improved protection against pertussis The international PERISCOPE project has been granted a 30 million Euro European subsidy in order to better map the immune response to pertussis infection and vaccination.
Chikungunya infections in the Caribbean region Since August 2014, there has been an increase in the number of Chikungunya patients in the Caribbean region. Travellers who visit the region can become infected there.
Dr. Els van Schie new director of Environment and Safety Dr. Els van Schie has been appointed RIVM Director of Environment and Safety as from 1 February 2015. She will succeed Dr. Marcel van Raaij and interim director Dr.
Release of QMRAspot v2 for quantitative microbial risk assessment of drinking water RIVM has developed a new version of QMRAspot (2.0), a user-friendly computational tool to calculate the risk of becoming infected by pathogenic microorganisms in drinking water.
Annoyance and health effects due to European transportation noise At least 20 million adults in Europe are annoyed by transportation noise in agglomerations, from motorways, airports or railways.
Statistical Program to Assess Dietary Exposure now available The Statistical Program to Assess Dietary Exposure (SPADE), developed by RIVM, is now available.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
Breast milk as indicator of environmental pollutants The 6th worldwide study into Persistent Organic Pollutants (POPs) in breast milk is about to commence.